Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-02

FDA Approved: BORTEZOMIB — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approves Fresenius Kabi USA's generic bortezomib injection under Original Application. Indications include multiple myeloma and mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)